These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 20823283)
21. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor. Vermitsky JP; Edlind TD Antimicrob Agents Chemother; 2004 Oct; 48(10):3773-81. PubMed ID: 15388433 [TBL] [Abstract][Full Text] [Related]
22. Acquired Flucytosine Resistance during Combination Therapy with Caspofungin and Flucytosine for Candida glabrata Cystitis. Charlier C; El Sissy C; Bachelier-Bassi S; Scemla A; Quesne G; Sitterlé E; Legendre C; Lortholary O; Bougnoux ME Antimicrob Agents Chemother; 2016 Jan; 60(1):662-5. PubMed ID: 26525799 [TBL] [Abstract][Full Text] [Related]
23. Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2. Hull CM; Bader O; Parker JE; Weig M; Gross U; Warrilow AG; Kelly DE; Kelly SL Antimicrob Agents Chemother; 2012 Dec; 56(12):6417-21. PubMed ID: 23027188 [TBL] [Abstract][Full Text] [Related]
24. Various cytosine/adenine permease homologues are involved in the toxicity of 5-fluorocytosine in Saccharomyces cerevisiae. Paluszynski JP; Klassen R; Rohe M; Meinhardt F Yeast; 2006 Jul; 23(9):707-15. PubMed ID: 16845689 [TBL] [Abstract][Full Text] [Related]
25. Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance. Biswas C; Chen SC; Halliday C; Martinez E; Rockett RJ; Wang Q; Timms VJ; Dhakal R; Sadsad R; Kennedy KJ; Playford G; Marriott DJ; Slavin MA; Sorrell TC; Sintchenko V J Vis Exp; 2017 Dec; (130):. PubMed ID: 29364212 [TBL] [Abstract][Full Text] [Related]
26. Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing. Spettel K; Barousch W; Makristathis A; Zeller I; Nehr M; Selitsch B; Lackner M; Rath PM; Steinmann J; Willinger B PLoS One; 2019; 14(1):e0210397. PubMed ID: 30629653 [TBL] [Abstract][Full Text] [Related]
27. Comparison of fks gene mutations and minimum inhibitory concentrations for the detection of Candida glabrata resistance to micafungin: A systematic review and meta-analysis. Bienvenu AL; Leboucher G; Picot S Mycoses; 2019 Sep; 62(9):835-846. PubMed ID: 31077631 [TBL] [Abstract][Full Text] [Related]
28. Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan. Khalifa HO; Arai T; Majima H; Watanabe A; Kamei K Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571826 [TBL] [Abstract][Full Text] [Related]
33. Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure. Arastehfar A; Daneshnia F; Salehi M; Yaşar M; Hoşbul T; Ilkit M; Pan W; Hagen F; Arslan N; Türk-Dağı H; Hilmioğlu-Polat S; Perlin DS; Lass-Flörl C Mycoses; 2020 Sep; 63(9):911-920. PubMed ID: 32413170 [TBL] [Abstract][Full Text] [Related]
34. A Review on Molecular Mechanisms of Antifungal Resistance in Lotfali E; Fattahi A; Sayyahfar S; Ghasemi R; Rabiei MM; Fathi M; Vakili K; Deravi N; Soheili A; Toreyhi H; Shirvani F Microb Drug Resist; 2021 Oct; 27(10):1371-1388. PubMed ID: 33956513 [No Abstract] [Full Text] [Related]
35. Amino acid substitutions in Erg11p of azole-resistant Candida glabrata: Possible effective substitutions and homology modelling. Nabili M; Abdollahi Gohar A; Badali H; Mohammadi R; Moazeni M J Glob Antimicrob Resist; 2016 Jun; 5():42-6. PubMed ID: 27436465 [TBL] [Abstract][Full Text] [Related]
36. Relative Contribution of the ABC Transporters Cdr1, Pdh1, and Snq2 to Azole Resistance in Candida glabrata. Whaley SG; Zhang Q; Caudle KE; Rogers PD Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30038038 [TBL] [Abstract][Full Text] [Related]
37. Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effect. Hope WW; Warn PA; Sharp A; Howard S; Kasai M; Louie A; Walsh TJ; Drusano GL; Denning DW Antimicrob Agents Chemother; 2006 Nov; 50(11):3680-8. PubMed ID: 16954320 [TBL] [Abstract][Full Text] [Related]
38. Loss of heterozygosity of FCY2 leading to the development of flucytosine resistance in Candida tropicalis. Chen YN; Lo HJ; Wu CC; Ko HC; Chang TP; Yang YL Antimicrob Agents Chemother; 2011 Jun; 55(6):2506-14. PubMed ID: 21422221 [TBL] [Abstract][Full Text] [Related]
39. New Mechanisms of Flucytosine Resistance in C. glabrata Unveiled by a Chemogenomics Analysis in S. cerevisiae. Costa C; Ponte A; Pais P; Santos R; Cavalheiro M; Yaguchi T; Chibana H; Teixeira MC PLoS One; 2015; 10(8):e0135110. PubMed ID: 26267134 [TBL] [Abstract][Full Text] [Related]